Pegylated phospholipids-based self-assembly with water-soluble drugs.
about
Small-sized polymeric micelles incorporating docetaxel suppress distant metastases in the clinically-relevant 4T1 mouse breast cancer modelStability influences the biodistribution, toxicity, and anti-tumor activity of doxorubicin encapsulated in PEG-PE micelles in mice.Targeted delivery of Doxorubicin by folic acid-decorated dual functional nanocarrierAn improved D-α-tocopherol-based nanocarrier for targeted delivery of doxorubicin with reversal of multidrug resistanceSmart micelle@polydopamine core-shell nanoparticles for highly effective chemo-photothermal combination therapy.Multifunctional superparamagnetic iron oxide nanoparticles for combined chemotherapy and hyperthermia cancer treatmentSynergistic and complete reversal of the multidrug resistance of mitoxantrone hydrochloride by three-in-one multifunctional lipid-sodium glycocholate nanocarriers based on simultaneous BCRP and Bcl-2 inhibition.Concepts and practices used to develop functional PLGA-based nanoparticulate systemsNanostructured lipid-carrageenan hybrid carriers (NLCCs) for controlled delivery of mitoxantrone hydrochloride to enhance anticancer activity bypassing the BCRP-mediated efflux.Epidermal growth factor receptor-targeted peptide conjugated phospholipid micelles for doxorubicin delivery.Polymer assisted entrapment of netilmicin in PLGA nanoparticles for sustained antibacterial activity.Surface analysis of PEGylated nano-shields on nanoparticles installed by hydrophobic anchors.Cationic amphiphilic drugs self-assemble to the core-shell interface of PEGylated phospholipid micelles and stabilize micellar structure.Anti-tumor activity of nanomicelles encapsulating CXCR4 peptide antagonist E5.Synthesis, Positron Emission Tomography Imaging, and Therapy of Diabody Targeted Drug Lipid Nanoparticles in a Prostate Cancer Murine Model.Cholecalciferol-PEG Conjugate Based Nanomicelles of Doxorubicin for Treatment of Triple-Negative Breast Cancer.Progress of nanoscience in China
P2860
Q33622043-E01D7D6E-862E-423A-8B53-04961121DF5CQ34199257-60225C97-EF3D-4EBE-BA5B-551CC5EF1756Q34473472-CBEBD5A9-25D0-4C45-98B5-AB26837F53ECQ34714270-A73B08F1-06B4-4CC5-9CB5-E0B645C61787Q35837864-CA240527-9CB8-479B-A951-7055BD60E4EDQ35866569-0CD4B4BE-A6F9-4144-9A1D-DA445112B14CQ37214483-88BDCF33-773C-44F3-81A0-249E81168815Q38086377-2D87D20C-F5A5-46D1-B4DC-5C6E85002B23Q38804702-01C49C4F-C0DB-4EE1-B71A-7FCFBE0660E4Q38852900-14C1AD4E-BFCF-4B62-AD3F-0FF83E0E758CQ38955018-3A1100D5-9897-4913-BEC2-5C326AD4F73AQ39167669-D29B2056-1B88-4A7B-9C28-EA24A92E5916Q39356586-99D3B799-B03F-4DEE-B73F-56E2275DA948Q41327051-2B95F08C-7DA7-46A8-A678-39C43EFB3B67Q44933611-48BE5C56-4905-4B44-A8F5-9919A2FC8ABAQ49743645-2BECC7B9-34B6-4754-9EDE-D296FCFEE419Q57238731-3E8AB673-7999-42B9-8A70-6778096E7101
P2860
Pegylated phospholipids-based self-assembly with water-soluble drugs.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Pegylated phospholipids-based self-assembly with water-soluble drugs.
@ast
Pegylated phospholipids-based self-assembly with water-soluble drugs.
@en
Pegylated phospholipids-based self-assembly with water-soluble drugs.
@nl
type
label
Pegylated phospholipids-based self-assembly with water-soluble drugs.
@ast
Pegylated phospholipids-based self-assembly with water-soluble drugs.
@en
Pegylated phospholipids-based self-assembly with water-soluble drugs.
@nl
prefLabel
Pegylated phospholipids-based self-assembly with water-soluble drugs.
@ast
Pegylated phospholipids-based self-assembly with water-soluble drugs.
@en
Pegylated phospholipids-based self-assembly with water-soluble drugs.
@nl
P2093
P1476
Pegylated phospholipids-based self-assembly with water-soluble drugs.
@en
P2093
Chunling Zhang
Ruiqi Wang
Wanliang Lu
Xiaoyan Lu
P304
P356
10.1007/S11095-009-0029-6
P50
P577
2009-12-22T00:00:00Z